Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25036
Title: Neutrophil to lymphocyte ratio predicts glucocorticoid resistance in polymyalgia rheumatica.
Austin Authors: Owen, Claire E ;McMaster, Christopher ;Liew, David F L ;Leung, Jessica L Y ;Scott, Andrew M ;Buchanan, Russell R C 
Affiliation: Rheumatology
Department of Medicine, University of Melbourne, Parkville, VIC, Australia
Molecular Imaging and Therapy
Olivia Newton-John Cancer Research Institute
School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia
Issue Date: Jan-2021
metadata.dc.date: 2020-10-12
Publication information: International Journal of Rheumatic Diseases 2021; 24(1): 56-62
Abstract: Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) correlate with disease activity in several rheumatic diseases; however, their utility in polymyalgia rheumatica (PMR) remains unclear. This study evaluated their relationship with disease activity and glucocorticoid resistance in PMR. Data for disease activity (PMR-AS) and full blood examination was obtained from a prospective observational cohort comprising newly diagnosed, steroid-naïve PMR patients treated with low-dose glucocorticoid therapy. Glucocorticoid resistance was defined as non-response to prednisolone 15 mg/d or initial response followed by flare (PMR-AS ≥ 9.35 or ∆ ≥6.6) upon weaning to 5 mg/d. Univariable Bayesian linear regression analysis of the relationship between PMR-AS (baseline and mean) and NLR and PLR was performed. Predictors of glucocorticoid resistance were identified using a multivariable outcome model, with variables derived from Bayesian model selection. Of the 32 included patients, 16 (50%) fulfilled the primary outcome measure of glucocorticoid resistance. These participants were older, typically female, and had higher baseline C-reactive protein than their glucocorticoid-responsive counterparts. A statistically significant relationship was identified between PMR-AS and both NLR (odds ratio [OR] 28.1; 95% CI 1.6-54.7) and PLR (OR 40.6; 95% CI 10.1-71.4) at baseline, with PLR also found to correlate with disease activity during follow-up (OR 15.6; 95% CI 2.7-28.2). Baseline NLR proved a statistically significant predictor of glucocorticoid-resistant PMR (OR 14.01; 95% CI 1.49-278.06). Baseline NLR can predict glucocorticoid resistance in newly diagnosed PMR patients. Both NLR and PLR may be reliable biomarkers of disease activity in PMR.
URI: https://ahro.austin.org.au/austinjspui/handle/1/25036
DOI: 10.1111/1756-185X.14000
ORCID: 0000-0002-2694-5411
0000-0001-8451-8883
0000-0002-3834-2706
PubMed URL: 33043616
Type: Journal Article
Subjects: glucocorticoids
lymphocytes
neutrophils
polymyalgia rheumatica
prognosis
Appears in Collections:Journal articles

Show full item record

Page view(s)

46
checked on Nov 28, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.